2nd Quarter - Report

TCH GROUP, LLC for AMGEN USA INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$40,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 21, 2008 $40,000 Replaced
2nd Quarter - Amendment Jul 22, 2008 $40,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 1145, HR 1908-Patent Reform Act of 2007. Specifically, issues related to intellectual property and process patents.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Medicare/Medicaid MMM

S.J. Resolution 305, Sense of the Senate regarding Medicare's National Coverage Determination of Erythropoieses-Stimulating-Agents (ESAs); S.J. Resolution 22, providing for Congressional Disapproval of a National Coverage Decision restricting Medicare Coverage of Erythropoeisis-Stimulating Agents (ESAs); S. 1983, The Children's Health Insurance Program Reauthorization Act of 2007; S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007. S.3101, H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE

Bills named: S. 3101 (110th), S. 2499 (110th), H.R. 6331 (110th), S. 1983 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.